PRGO Q3 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+2.1% YoY

Gross Profit

$411M36.6% margin

Operating Income

$62M5.5% margin

Net Income

$14M1.3% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

-5.8%

Cash Flow

Operating Cash Flow

$125M

Free Cash Flow

$93M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$6.0B

Stockholders' Equity

$4.7B

Cash & Equivalents

$598M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	+2.1%
Gross Profit	$411M	$363M	+13.3%
Operating Income	$62M	$33M	+87.6%
Net Income	$14M	-$49M	+128.7%

Revenue Segments

Consumer Self-Care Americas

$704M63%

Consumer Self-Care International

$420M37%

Geographic Segments

UNITED STATES

$690M61%

Europe

$400M35%

Other Geographical Areas

$34M3%

IRELAND

$12M1%